Osmotic delivery systems and piston assemblies for use therein
View Patent ↗An osmotic delivery system is disclosed for delivering an active agent formulation to a fluid environment. The osmotic delivery system typically comprises a reservoir having a lumen that contains the active agent formulation and an osmotic agent formulation and a piston assembly positioned in the lumen to isolate the active agent formulation from the osmotic agent formulation. The piston assembly typically comprises a body constructed and arranged for positioning in the lumen. The body is typically made of a polymeric material that is, for example, resistant to leaching in an organic solvent. In one embodiment, the body is a columnar body having a rim at a distal end thereof for engaging and sealing against a wall of the reservoir and the piston assembly further comprises a spring retained at the distal end of the columnar body for biasing the rim of the columnar body against the wall of the reservoir.
1. An osmotic delivery system for delivering an active agent formulation to a fluid environment, comprising:
a reservoir comprising an interior wall defining a lumen that contains the active agent formulation and an osmotic agent formulation; and
a piston assembly positioned in the lumen to isolate the active agent formulation from the osmotic agent formulation, wherein the piston assembly comprises a columnar body that (i) has a core made of a polymeric material comprising an ultra high molecular weight polyethylene, (ii) produces volatile leachates of less than about 1.4 μg/ml when exposed to benzyl benzoate at 40° C. for at least about 45 days, and (iii) further comprises a rim at a distal end thereof for engaging and sealing against the interior wall of the reservoir, and a spring retained at the distal end for biasing the rim against the wall of the reservoir.
2. The osmotic delivery system of claim 1 , wherein the spring is retained in a cavity at the distal end of the columnar body.
3. The osmotic delivery system of claim 1 , wherein the spring is a radial spring.
4. The osmotic delivery system of claim 3 , wherein the spring is a canted coil spring.
5. The osmotic delivery system of claim 1 , wherein the spring is made of a non-reactive metal.
6. The osmotic delivery system of claim 1 , further comprising a semipermeable membrane positioned at a first end of the reservoir adjacent the osmotic agent formulation.
7. The osmotic delivery system of claim 6 , further comprising a flow modulator positioned at a second end of the reservoir adjacent the active agent formulation, said flow modulator having an orifice for delivering the active agent formulation to the fluid environment.
8. The osmotic delivery system of claim 1 , wherein the piston assembly is movable within the reservoir in response to pressure within the reservoir.
9. The osmotic delivery system of claim 1 , wherein the active agent formulation is a suspension formulation comprising a suspension vehicle comprising one or more organic solvent.
10. The osmotic delivery system of claim 9 , wherein the organic solvent is selected from the group consisting of benzyl benzoate and benzyl alcohol.
11. The osmotic delivery system of claim 10 , wherein the suspension formulation further comprises a particle formulation comprising one or more interferon.
12. The osmotic delivery system of claim 11 , wherein the interferon is selected from the group consisting of alpha interferon, beta interferon, delta interferon, gamma interferon, omega interferon, lambda interferon, tau interferon, and mixtures thereof.
13. The osmotic delivery system of claim 12 , wherein the interferon is omega interferon.
14. The osmotic delivery system of claim 12 , wherein the interferon is beta interferon.
15. The osmotic delivery system of claim 11 , wherein the reservoir is made of an impermeable material.
16. The osmotic delivery system of claim 1 , wherein the active agent formulation is a suspension formulation comprising a particle formulation comprising one or more insulinotropic peptide.
17. The osmotic delivery system of claim 16 , wherein the insulinotropic peptide is selected from the group consisting of glucagon like protein 1 (GLP-1) and exendin-4.
18. The osmotic delivery system of claim 1 , wherein
the reservoir is made of a titanium alloy;
the active agent formulation is a suspension formulation comprising a particle formulation comprising interferon, sucrose, methionine, citric acid monohydrate, and sodium citrate, and a suspension vehicle comprising benzyl benzoate and polyvinylpyrrolidone;
the osmotic agent formulation comprises two cylindrical tablets, each tablet comprising sodium chloride salt with cellulosic and povidone binders;
the spring retained at the distal end for biasing the rim against the wall of the reservoir is a canted coil spring;
the osmotic delivery system further comprising,
a semipermeable membrane positioned at a first distal end of the reservoir adjacent the osmotic agent formulation, wherein the semipermeable membrane comprises polyurethane; and
a flow modulator positioned at a second distal end of the reservoir adjacent the active agent formulation, wherein the flow modulator comprises polyetheretherketone.
19. The osmotic delivery system of claim 18 , wherein in the system is implantable in a subject.
20. The osmotic delivery system of claim 1 , wherein in the system is implantable in a subject.
21. A method of manufacturing the osmotic delivery system of claim 1 , comprising
providing the reservoir, the active agent formulation, the osmotic agent formulation, the piston assembly, a semipermeable membrane and a flow modulator;
assembling the reservoir, the active agent formulation, the osmotic agent formulation, the piston assembly, the semipermeable membrane and the flow modulator, such that the piston assembly is positioned in the lumen to isolate the active agent formulation from the osmotic agent formulation, the semipermeable membrane is positioned at a first distal end of the reservoir adjacent the osmotic agent formulation, and the flow modulator is positioned at a second distal end of the reservoir adjacent the active agent formulation.
22. An osmotic delivery system for delivering an active agent formulation to a fluid environment, comprising:
a reservoir having a lumen which contains the active agent formulation and an osmotic agent formulation, wherein the reservoir comprises a titanium alloy;
the active agent formulation comprising a suspension formulation comprising (i) a particle formulation comprising interferon, sucrose, methionine, citric acid monohydrate, and sodium citrate, and (ii) a suspension vehicle comprising benzyl benzoate and polyvinylpyrrolidone;
the osmotic agent formulation comprising two cylindrical tablets, each tablet comprising sodium chloride salt with cellulosic and povidone binders;
a piston assembly positioned in the lumen to isolate the active agent formulation from the osmotic agent formulation, wherein (i) the piston assembly comprises a columnar body having an hour-glass shape constructed and arranged for positioning in the lumen, and (ii) the columnar body having a core made of an ultra-high molecular weight polyethylene that produces volatile leachates of less than about 1.4 μg/ml when exposed to benzyl benzoate at 40° C. for at least about 45 days, further the columnar body comprises a rim at a distal end thereof for engaging and sealing against a wall of the reservoir and a canted coil spring retained at the distal end for biasing the rim against the wall of the reservoir;
a semipermeable membrane positioned at a first distal end of the reservoir adjacent the osmotic agent formulation, wherein the semipermeable membrane comprises polyurethane; and
a flow modulator positioned at a second distal end of the reservoir adjacent the active agent formulation, wherein the flow modulator comprises polyetheretherketone.